Themistocles L. Assimes, MD PhD

Themistocles L. Assimes, MD PhD


Bio:   Dr. Themistocles (Tim) Assimes, MD PhD, is a board-certified adult cardiologist and an Associate Professor of Medicine at Stanford University in the Division of Cardiovascular Medicine. Tim grew up in Montreal, Canada, where he received his medical degree from McGill University in 1994. He then pursued training in surgery for nearly two years before switching into internal medicine. He completed his residency in internal medicine as well as a masters degree in Epidemiology and Biostatistics at McGill before moving to Stanford University in 2001 to pursue fellowship training in cardiology. During his fellowship and initial faculty years at Stanford University, he also completed a PhD in Epidemiology and Biostatistics. Dr. Assimes currently devotes a majority of his time performing advanced population based research on the genomic causes of heart attacks and the common conditions that predispose people to heart attacks including high cholesterol, smoking, diabetes, obesity, high blood pressure, and insulin resistance. He has gained substantial experience collaborating with scientists at the international level by representing Stanford in large consortia meta analyzing genetic and genomic data. These efforts go beyond the standard SNP by SNP analyses and include analyses, interpretation, and integration of expression and allelic imbalance SNPs, genetic risk scores, Mendelian randomization, epigenetic, and gene set enrichment analyses for the identification of novel pathways of CHD in multi-ethnic populations. Concurrently, he teaches general cardiology as well as echocardiography to medical students, residents, and cardiology fellows-in-training at the Stanford affiliated Palo Alto VA hospital.

Professional Education

  • PhD, McGill University, Epidemiology & Biostatistics (2008)
  • Fellowship: Stanford University (2005) CA
  • Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2004)
  • MS, McGill University, Epidemiology & Biostatistics (2001)
  • Residency: McGill University Health Center (2000) Canada
  • ABIM, Internal Medicine, (certification not maintained beyond 2009) (1999)
  • Medical Education: Mcgill University (1994) Canada

Honors & Awards

  • A pilot RNA-seq study among Long Life Study participants of the WHI, NHLBI (03/01/2015-08/31/2015)
  • Chief Medical Resident, McGill University Medical Center - Royal Victoria Hospital (1999-2000)
  • Determinants of Insulin mediated glucose update in South Asians, NIDDK (04/01/2011-01/31/2015)
  • Edwin L. Alderman award for excellence in Clinical Cardiovascular Research, Stanford University School of Medicine (2004, 2005)
  • Elected Fellow of the American Heart Association (FAHA), council of Epidemiology and Prevention, American Heart Association (03/01/2016)
  • Integrative genomics and risk of CHD and related phenotypes in the Women’s Health Initiative, NHLBI (03/28/2013-03/27/2016)
  • J.W. McConnell Scholarship, McGill Universtiy (1989-1994)
  • Utility of a novel measure of telomere length in predicting CVD outcomes & response to statins, Telomere Diagnostics, Inc. (02/01/2015-04/30/17)
  • Utility of the Aviir risk score in predicting incident coronary heart disease in the WHI (PI), Aviir, Inc. (08/01/2011-07/31/2013)

Administrative Appointments

  • Leadership Committee, Council of Functional Genomics and Translational Biology, American Heart Association (2016 - 2018)
  • Member, Ancillary Studies Committee, Women's Health Initiative (2010 - Present)
  • Membership and Communications Committee, Council of Epidemiology and Prevention, American Heart Organization (2016 - 2018)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.